Eli Lilly Seeks NHS Drug Price Increases in Exchange for UK Investment
US pharmaceutical giant Eli Lilly is reportedly pushing for higher drug prices from the NHS, linking the increases to its investment plans within the United Kingdom and expressing optimism about ongoing talks with ministers.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)Sources
Eli Lilly pushes for NHS drug price increases in return for its UK investment
US pharmaceutical group ‘optimistic’ about reaching deal with British government
Read full article →Mounjaro maker wants NHS drug price rises in return for more investment in UK
US firm Eli Lilly, which is also pushing for end to rebate scheme, optimistic about talks with ministers The US pharmaceutical group behind the Mounjaro weight-loss drug has said it will unpause its UK investments if ministers agree to regularly increase NHS drug prices and end a rebate scheme. Patrik Jonsson, the president of Eli Lilly’s international business, said the company was in talks with UK ministers and that he was optimistic about reaching an agreement this summer for Britain to pa...
By Lauren Almeida
Read full article →
